Charles River Laboratories International, Inc. (CRL) Q1 2017 Earnings Results

Charles River Laboratories Beats on EPS, Stock Down 1.6%

Charles River Laboratories reported an EPS of $1.29, exceeding expectations by 10.53%. However, the stock reacted negatively, declining by 1.6%. This drop may reflect broader market conditions or investor sentiment despite the positive earnings surprise.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.29	N/A	+10.53%

Management

Management commentary

Tone: Unknown

No transcript is on record for this earnings call, so the analysis is based solely on the numerical results reported.

Charles River Laboratories Beats on EPS, Stock Down 1.6%

Key numbers

Management commentary

Charles River Laboratories International, Inc.

More earnings this week

Charles River Laboratories Beats on EPS, Stock Down 1.6%

Key numbers

Management commentary